Addressing psychological distress related to Ebola in Central Uganda
Proposal to Address the Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Mubende District in Central Uganda (Ebola+D Project)
This study is testing a new program to help people in Central Uganda who are feeling mentally distressed because of Ebola by providing them with support and care over a year.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | MRC/UVRI and LSHTM Uganda Research Unit Academic / other |
| Locations | 1 site (Kampala) |
| Trial ID | NCT06093646 on ClinicalTrials.gov |
What this trial studies
This project aims to screen individuals attending healthcare facilities in Mubende District for psychological distress associated with Ebola Virus Disease using the WHO Self Report Questionnaire. Those identified with significant distress will receive the Ebola+D intervention, a collaborative model designed to address their mental health and psychosocial needs. Participants will be followed for 12 months with assessments at baseline, 3 months, and 12 months to evaluate the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates include community members aged 18 and above from Mubende District who exhibit significant psychological distress as indicated by the WHO SRQ-20.
Not a fit: Patients who are unable to engage with the research process due to sensory or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental health and psychosocial well-being of individuals affected by Ebola in the region.
How similar studies have performed: While there have been various interventions addressing mental health in post-epidemic contexts, this specific approach targeting Ebola-related psychological distress is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Community member of Mubende district staying within the catchment area of the primary health care facility (PHCF); * 18years and above, * Able to communicate in either English or Luganda (local language spoken in the study region and the language into which the questionnaires will be translated), * Has a WHO SRQ-20 score of 6 and above (except for Ebola survivors who are eligible even when their SRQ-20 score is either below or above 6). - Exclusion Criteria: * Unable to engage with the research process for any reason that may include sensory impairment or cognitive impairment
Where this trial is running
Kampala
- Mubende Regional Referal Hospital — Kampala, Uganda (Recruiting)
Study contacts
- Principal investigator: Eugene Kinyanda, PhD — MRC/UVRI and LSHTM Uganda Research unit, Uganda
- Study coordinator: Richard S. Mpango, PhD
- Email: Richard.Mpango@mrcuganda.org
- Phone: 0772592504
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.